Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatic tumors].

A Martínez Valverde1, M Baca Cost, T Acha García

  • 1Departamento de Pediatría de la Facultad de Medicina, Hospital Regional Carlos Haya, Málaga.

Anales Espanoles De Pediatria
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Focal nodular hyperplasia: A diagnosis to consider in a hepatic mass].

Anales de pediatria (Barcelona, Spain : 2003)·2015
Same author

[Focal delayed post-chickenpox myelitis. Case report. A review and update].

Anales de pediatria (Barcelona, Spain : 2003)·2014
Same author

[Infantile spinal atrophy: our experience in the last 25 years].

Anales de pediatria (Barcelona, Spain : 2003)·2014
Same author

[Is the wait-and-see approach in Gorham syndrome a therapeutic option?].

Anales de pediatria (Barcelona, Spain : 2003)·2014
Same author

[Validation of an acute bronchiolitis severity scale].

Anales de pediatria (Barcelona, Spain : 2003)·2013
Same author

[Complex febrile seizures: study of the associated pathology and practical use of complementary tests].

Anales de pediatria (Barcelona, Spain : 2003)·2013
Same journal

[Sponsorship, authorship, and responsibility].

Anales espanoles de pediatria·2005
Same journal

[Recurrent hematuria].

Anales espanoles de pediatria·2002
Same journal

[Congenital hyperferritinemia and cataract syndrome].

Anales espanoles de pediatria·2002
Same journal

[Renal angiomyolipoma: a case with a difficult diagnosis].

Anales espanoles de pediatria·2002
Same journal

[Myocardial stunning].

Anales espanoles de pediatria·2002
Same journal

[Exogenous surfactant. A rescue treatment in a neonate with varicella complicated with pneumonia].

Anales espanoles de pediatria·2002
See all related articles

This study on liver neoplasms found malignant tumors more frequent than benign ones. Therapeutic interventions like ADR and CDDP showed potential for increasing survival rates in patients.

Area of Science:

  • Hepatology
  • Oncology
  • Tumor Biology

Context:

  • Liver neoplasms represent a significant health concern, with varying clinical presentations between benign and malignant types.
  • Understanding the initial symptoms and epidemiological characteristics of liver tumors is crucial for timely diagnosis and effective management.
  • Comparative analysis of treatment outcomes for benign versus malignant liver neoplasms informs therapeutic strategies.

Purpose:

  • To investigate the presentation patterns of benign and malignant liver neoplasms.
  • To compare the therapeutic outcomes between patients with benign and malignant liver tumors.
  • To evaluate the impact of specific chemotherapeutic agents on survival rates for liver neoplasms.

Summary:

  • Malignant liver neoplasms were more prevalent in the studied population compared to benign tumors.

Related Experiment Videos

  • Abdominal mass was a common initial symptom, though malignant cases often presented with more generalized complaints.
  • Adjuvant therapy with Adriamycin (ADR) or Cisplatin (CDDP) demonstrated a positive correlation with increased patient survival.
  • Impact:

    • Highlights the higher incidence of malignant liver tumors in the studied cohort.
    • Provides insights into differentiating clinical presentations of benign and malignant liver neoplasms.
    • Suggests the efficacy of ADR and CDDP in improving survival outcomes for liver cancer patients, warranting further clinical investigation.